Award
Delivery Order #SPE2DP26F3468
Delivery Order for Erythromycin Ophthalmic by DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$51.30
Ceiling
$51.30
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 11, 2026
Identifier
SPE2DP26F3468
NAICS
424210
This award is a delivery order under the definitive pharmaceutical supply contract vehicle, specifically focusing on a delivery of erythromycin ophthalmic product. The recipient, DMS Pharmaceutical Group Inc., is a pharmaceutical distributor known for supplying critical medications to federal health agencies. This specific contract enhances the agency's capability to maintain a reliable inventory of essential ophthalmic antibiotics, crucial for treating eye infections and supporting public health. The scope involves the delivery of erythromycin ophthalmic formulation, a well-established antibiotic application in ocular treatments. This contract is part of a larger, ongoing definitive contract with DMS, reflecting a strategic procurement approach rather than a one-off purchase. The delivery order was recently awarded and scheduled for prompt performance on the specified date in early 2026. It continues the agency's long-term engagement with DMS Pharmaceutical Group, supporting sustained healthcare provisioning through specialized pharmaceutical products.
Description
8511971601!ERYTHROMYCIN OPHTHA